glp-1 news today 2025 october 9 KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Alarming rise in weight loss
Description
Semaglutide, marketed under names like Wegovy and Ozempic, is a GLP-1 receptor agonist

From a clinical pharmacology perspective, delayed gastric emptying could potentially result in pharmacokinetic (PK) and pharmacodynamic (PD) drug interactions when co-administered with an oral small molecule

It has been observed that insulin receptors are overexpressed in most thyroid tumors as an early step in thyroid carcinogenesis [15]

I think we were getting there

Oral tablets do not require the use of needles are typically taken daily can result in side effects such as nausea, vomiting, constipation, and abdominal pain must be taken on an empty stomach first thing in the morning, without eating for 30 minutes afterward Injections require the use of needles are typically taken once per week may cause side effects such as injection site reactions but may also cause nausea, vomiting, constipation, and abdominal pain can be taken regardless of whether you consume food or liquid beforehand or afterward You can inject semaglutide into your upper arm, thigh, or stomach
As GLP-1 receptor agonists are increasingly used for weight management and glycemic control, clinicians may consider thyroid dysfunction in the differential diagnosis when relevant symptoms arise during therapy, even in patients without traditional risk factors
